Atlas Trials

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

Clinical trial NCT07284992 · RECRUITING

Trial details

NCT number
NCT07284992
Sponsor
Shandong Provincial Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal CancerAdvanced Stage Colorectal CancerRadiotherapy
Start date
2025-09-12
Primary completion
2028-11-30
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.